Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A C Altamura

Showing results (31-40 of 113) with videos related to

Pageof 12
Sort By:
European Journal of Clinical Pharmacology|August 17, 1977
Plasma and intracellular kinetics of lithium after oral administration of various lithium saltsA C Altamura, R Gomeni, E Sacchetti, et al.
Archiv Fur Psychiatrie Und Nervenkrankheiten|December 28, 1977
Plasma renin activity in primary and secondary depressionA C Altamura, A Morganti, E Smeraldi, et al.
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry|December 17, 2009
Duration of untreated illness as a predictor of treatment response and remission in obsessive-compulsive disorderB Dell'Osso, M Buoli, E Hollander, et al.
Psychopharmacology|January 1, 1982
Influence of age on mianserin pharmacokineticsA C Altamura, T Melorio, G Invernizzi, et al.
International Journal of Clinical Practice|September 20, 2007
Duration of untreated illness in major depressive disorder: a naturalistic studyA C Altamura, B Dell'Osso, E Mundo, et al.
International Clinical Psychopharmacology|January 1, 1989
Efficacy and tolerability of fluoxetine in the elderly: a double-blind study versus amitryptilineA C Altamura, M Percudani, G Guercetti, et al.
Acta Vitaminologica Et Enzymologica|January 1, 1975
N1-Methylnicotinamide urinary output in multiple sclerosis affected patientsE Sacchetti, A C Altamura, E Smeraldi, et al.
The British Journal of Psychiatry. Supplement|September 1, 1988
The evidence for 20mg a day of fluoxetine as the optimal dose in the treatment of depressionA C Altamura, S A Montgomery, J F Wernicke
International Clinical Psychopharmacology|September 1, 1999
Venlafaxine in social phobia: a study in selective serotonin reuptake inhibitor non-respondersA C Altamura, R Pioli, M Vitto, et al.
Epidemiology and Psychiatric Sciences|January 12, 2016
The association between the serotonin and dopamine neurotransmitters and personality traitsG Delvecchio, M Bellani, A C Altamura, et al.
Pageof 12

Showing results (31-40 of 113) with videos related to

Sort By:
Pageof 12
European Journal of Clinical Pharmacology|August 17, 1977
Plasma and intracellular kinetics of lithium after oral administration of various lithium saltsA C Altamura, R Gomeni, E Sacchetti, et al.
Archiv Fur Psychiatrie Und Nervenkrankheiten|December 28, 1977
Plasma renin activity in primary and secondary depressionA C Altamura, A Morganti, E Smeraldi, et al.
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry|December 17, 2009
Duration of untreated illness as a predictor of treatment response and remission in obsessive-compulsive disorderB Dell'Osso, M Buoli, E Hollander, et al.
Psychopharmacology|January 1, 1982
Influence of age on mianserin pharmacokineticsA C Altamura, T Melorio, G Invernizzi, et al.
International Journal of Clinical Practice|September 20, 2007
Duration of untreated illness in major depressive disorder: a naturalistic studyA C Altamura, B Dell'Osso, E Mundo, et al.
International Clinical Psychopharmacology|January 1, 1989
Efficacy and tolerability of fluoxetine in the elderly: a double-blind study versus amitryptilineA C Altamura, M Percudani, G Guercetti, et al.
Acta Vitaminologica Et Enzymologica|January 1, 1975
N1-Methylnicotinamide urinary output in multiple sclerosis affected patientsE Sacchetti, A C Altamura, E Smeraldi, et al.
The British Journal of Psychiatry. Supplement|September 1, 1988
The evidence for 20mg a day of fluoxetine as the optimal dose in the treatment of depressionA C Altamura, S A Montgomery, J F Wernicke
International Clinical Psychopharmacology|September 1, 1999
Venlafaxine in social phobia: a study in selective serotonin reuptake inhibitor non-respondersA C Altamura, R Pioli, M Vitto, et al.
Epidemiology and Psychiatric Sciences|January 12, 2016
The association between the serotonin and dopamine neurotransmitters and personality traitsG Delvecchio, M Bellani, A C Altamura, et al.
Pageof 12